Massimiliano De Paola

Dr. Massimiliano De Paola

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MBMichael Brines
Michael Brines
NPNimesh S. A. Patel
Nimesh S. A. Patel
PVPia Villa
Pia Villa
CBCourtenay Brines
Courtenay Brines
TMTiziana Mennini
Tiziana Mennini
ACAnthony Cerami
Anthony Cerami
Erythropoietin (EPO), a member of the type 1 cytokine superfamily, plays a critical hormonal role regulating erythrocyte production as well as a paracrine/autocrine role in which locally produced EPO protects a wide variety of tissues from diverse injuries. Significantly, these functions are mediated by distinct receptors: hematopoiesis via the EPO receptor homodimer and tissue protection via a heterocomplex composed of the EPO receptor and CD131, the β common receptor. In the present work, we have delimited tissue-protective domains within EPO to short peptide sequences. We demonstrate that helix B (amino acid residues 58–82) of EPO, which faces the aqueous medium when EPO is bound to the receptor homodimer, is both neuroprotective in vitro and tissue protective in vivo in a variety of models, including ischemic stroke, diabetes-induced retinal edema, and peripheral nerve trauma. Remarkably, an 11-aa peptide composed of adjacent amino acids forming the aqueous face of helix B is also tissue protective, as confirmed by its therapeutic benefit in models of ischemic stroke and renal ischemia–reperfusion. Further, this peptide simulating the aqueous surface of helix B also exhibits EPO's trophic effects by accelerating wound healing and augmenting cognitive function in rodents. As anticipated, neither helix B nor the 11-aa peptide is erythropoietic in vitro or in vivo . Thus, the tissue-protective activities of EPO are mimicked by small, nonerythropoietic peptides that simulate a portion of EPO's three-dimensional structure.

18 October 2013 in ACS Nano
Verified
Journal Article
Closed access
SPSimonetta Papa
Simonetta Papa
Filippo RossiFilippo Rossi
Filippo Rossi
RFRaffaele Ferrari
Raffaele Ferrari
AMAlessandro Mariani
Alessandro Mariani
MPMassimiliano De Paola
Massimiliano De Paola
Pietro VeglianesePietro Veglianese
Pietro Veglianese

1 January 2016 in Biomaterials
Verified
Journal Article
Closed access
SPSimonetta Papa
Simonetta Papa
ICIlaria Caron
Ilaria Caron
EEEugenio Erba
Eugenio Erba
NPNicolò Panini
Nicolò Panini
MPMassimiliano De Paola
Massimiliano De Paola
Pietro VeglianesePietro Veglianese
Pietro Veglianese

30 December 2019 in ACS Nano
Verified
Journal Article
Closed access
IVIrma Vismara
Irma Vismara
SPSimonetta Papa
Simonetta Papa
VVValeria Veneruso
Valeria Veneruso
Emanuele MauriEmanuele Mauri
Emanuele Mauri
AMAlessandro Mariani
Alessandro Mariani
Pietro VeglianesePietro Veglianese
Pietro Veglianese

1 January 2014 in Journal of Controlled Release
Verified
Journal Article
Closed access
SPSimonetta Papa
Simonetta Papa
RFRaffaele Ferrari
Raffaele Ferrari
MPMassimiliano De Paola
Massimiliano De Paola
Filippo RossiFilippo Rossi
Filippo Rossi
AMAlessandro Mariani
Alessandro Mariani
Pietro VeglianesePietro Veglianese
Pietro Veglianese

1 May 2018 in Journal of Controlled Release
Verified
Journal Article
Closed access
SPS. Papa
S. Papa
IVI. Vismara
I. Vismara
AMA. Mariani
A. Mariani
MBMario Barilani
Mario Barilani
SRS. Rimondo
S. Rimondo
Pietro VeglianesePietro Veglianese
Pietro Veglianese